Back to Journals » Journal of Hepatocellular Carcinoma » Volume 5

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Total article views   Abstract views HTML views PDF downloads Totals
2,024 Dovepress* 1,441 396+ 382 1,837
PubMed Central* 0 187 45 187
Totals 1,441 583 427 2,024
*Since 19 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar